<DOC>
	<DOCNO>NCT01548638</DOCNO>
	<brief_summary>This preliminary open-label study determine whether medication call galantamine ( Brand Name : Razadyne ) help smoker quit whether reduces cognitive problem smoker experience quit attempt .</brief_summary>
	<brief_title>Effect Galantamine Smoking Abstinence</brief_title>
	<detailed_description>Galantamine , FDA-approved treatment Alzheimer 's disease , use treat cognitive impairment enhance acetylcholine inhibition enzyme , acetylcholinesterase . We propose open-label pilot feasibility study short-term ( 6 week ) treatment galantamine . Sixteen chronic smoker undergo validated procedure screen new medication . Following initial 4-week drug run-up phase ( 8mg daily galantamine-ER ) , medication dose increase 16 mg daily galantamine-ER fifth sixth week study . At begin Week 6 , smoker receive brief counsel make 7-day quit attempt . Following completion study , participant offer standard smoke cessation treatment . Subjects perform work memory task ( Visual/Spatial N-Back ) , sustain attention task ( Continuous Performance Task ; CPT ) , recall memory task ( Word Recognition ) , cognitive flexibility task ( Wisconsin Card Sort Test ) , response inhibition task ( Stop Signal Task ) . The primary outcome ability remain abstinent 7-day quit attempt . Secondary outcome include change cognitive performance , adherence , side effect . This pilot study provide information role cholinergic system brief abstinence whether enhance acetylcholine reduces abstinence-induced cognitive symptom promote smoke relapse . Information obtain study may establish cognitive performance measure endophenotypes nicotine dependence .</detailed_description>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>1 . Smokers 18 60 year age selfreport smoke least 10 cigarette ( menthol nonmenthol ) per day least last 6 month . 2 . Healthy determine Study Physician , base medical evaluation include medical history physical examination , psychiatric evaluation . 3 . Capable give write informed consent , include compliance requirement restriction list combined consent Health Insurance Portability Accountability Act ( HIPAA ) form . 4 . Women childbearing potential must consent use medically accept method birth control participate study ( e.g. , condoms spermicide , oral contraceptive , Depoprovera injection , contraceptive patch , tubal ligation ) . 1 . Smoking Behavior Use chew tobacco , snuff , and/or snus . Current enrollment smoking cessation program , use smoke cessation medication last month plan either next 2 month . Provide carbon monoxide ( CO ) breath sample read less 10ppm Medical Screening Baseline visit . 2 . Alcohol/Drugs Lifetime history substance abuse ( nicotine ) and/or currently receive treatment substance abuse ( e.g. , alcohol , opioids , cocaine , stimulant , Phencyclidine ( PCP ) , benzodiazepine , study prohibit medications/recreational drug ) determine selfreport phone screen and/or MINI Medical Screening . Current alcohol consumption exceed 25 standard drinks/week past 6 month . Providing breath alcohol concentration ( BrAC ) read great equal 0.01 Medical Screen Baseline session . A positive urine drug screen cocaine , amphetamine , methamphetamine , benzodiazepine , PCP , methadone , barbiturate , opiates Medical Screening , Baseline visit , Testing day . 3 . Medical Women pregnant , plan pregnancy next 3 month , lactate ; female subject childbearing potential shall undergo urine pregnancy test prior enrollment must agree write use approve method contraception . Pregnancy test conduct Medical Screening , Baseline visit , Testing day . Diagnosis Alzheimer 's Disease dementia . Current treatment cancer diagnose cancer ( except basal cell carcinoma ) past 6 month . Liver/kidney failure , peptic ulcer disease , benign prostate hypertrophy Asthma chronic obstructive pulmonary disease ( COPD ) History ( last 6 month ) abnormal heart rhythm , tachycardia and/or cardiovascular disease ( stroke , angina , heart attack ) . Serious unstable disease within past 6 month , determine Study Physician . Any impairment ( physical and/or neurological ) include visual impairment prevent cognitive task performance . Uncontrolled high blood pressure ( systolic &gt; 150 diastolic &gt; 90 ) Hearing impairment , significant hearing loss ( 20 % either ear ) , cochlear implant , bilateral hearing aid . History brain injury . History epilepsy seizure disorder . Color Blindness . Low borderline intellectual functioning determine receive score less 90 Shipley Institute Living Scale ( SILS ) correlate Wechsler Adult Intelligence ScaleRevised ( WAISR ) Estimated Intelligence Quotient ( IQ ) Test ( administer Medical Screening ) . 4 . Psychiatric Exclusion ( determine selfreport phone screen and/or MINI Medical Screening ) Current diagnosis major depression . Persons history major depression , remission 6 month longer , eligible , provide exclude base medication ( ) . Suicide risk score MINI great 0 . History current diagnosis schizophrenia , psychosis , bipolar disorder . Current past hypomanic/manic episode . Current history diagnosis AttentionDeficit/Hyperactivity Disorder ( ADHD ) . 5 . Medication Current use , recent discontinuation ( within last month ) form smoke cessation medication ( i.e. , Zyban , Wellbutrin , Wellbutrin sustainedrelease ( SR ) , Chantix , nicotine replacement therapy ) . Current use , recent discontinuation ( within last 60 day ) plan use follow medication : Antianxiety panic disorder medication . Antipsychotic medication . Moodstabilizers ( Lithium , Lamictal/lamotrigine , Neurontin/gabapentin , Topamax/topiramate , valproic acid , Tegretol/carbamazepine ) Antidepressants ( e.g. , Wellbutrin , monoamine oxidase inhibitor ( MAOIs ) , selective serotonin reuptake inhibitor ( SSRIs ) , tricyclic antidepressant ) . Prescription stimulant ( e.g. , Provigil , Ritalin , Adderall ) . Systemic Steroids ( e.g. , Prednisone ) . Current use ( use past 60 day ) : Alzheimer 's disease medication ( e.g. , Acetylcholinesterase inhibitor ( ACIs ) , Aricept/donepezil , Exelon/rivastigmine , Tacrine , memantine ) . Parkinson 's disease medication ( e.g. , Cogentin/benztropine ) . Irritable bowel syndrome medication ( e.g. , Dicylomine/Bentyl ) . Heart medication ( e.g. , quinidine Procardia/nifedipine ) . Peptic ulcer disease medication ( e.g , Zantac/ranitidine ) . Muscle relaxant ( e.g. , Soma/carisoprodol , Anectine/succinylcholine ) . Antifungal medication ( e.g. , Nizoral/ketoconazole ) . Antiseizure medication ( e.g. , Ativan , Banzel , Carbatrol , Dilantin , Lamictal , Gabitril , Lyrica , Neurontin , Tegretol , Topamax ) . COPD medication ( e.g. , Atrovent/Ipratropium Bromide ) . Blood pressure medication ( e.g. , Inversine/Mecamylamine ) . Urinary retention medication ( Duvoid/bethanechol , Proscar/finasteride , Avodart/dutasteride , Dibenzyline/phenoxybenzamine , Regitine/phentolamine ) . Eye medication ( e.g. , Atropine ) . Daily use : Opiatecontaining medication chronic pain ( Duragesic/fentanyl patch , Percocet , Oxycontin ) . Medication asthma ( albuterol , Serevent , Combivent , Advair , Flovent , Azmacort , Symbicort ) . Known allergy study medication . Participants shall instruct refrain use study prohibit drug ( note participant allow take prescription medicine exclusion list ) throughout participation study . 6 . General Exclusion Current enrollment plan enroll another research program next 2 month . Any medical condition , illness , disorder , concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . Inability provide inform consent complete study task determine Principal Investigator . Completion cognitive test study center within last 6 month . Able effectively communicate English ( read , write , speak ) . Missing 2 consecutive session , 3 session medication period . Missing 2 consecutive dos medication period . Missing 3 dos throughout medication period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Tobacco</keyword>
	<keyword>Smoking</keyword>
	<keyword>Galantamine</keyword>
</DOC>